Home
About
Our History
Senior Management
Board Of Directors
Medical Advisory Board Members
Products
The VenoValve
®
CoreoGraft
®
– Bypass Graft
Contact
Careers
Investors
Overview
Investor Presentation
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Proxy Information
Home
About
Our History
Senior Management
Board Of Directors
Medical Advisory Board Members
Products
The VenoValve™
CoreoGraft™ – Bypass Graft
Contact
Careers
Investors
Overview
Investor Presentation
News / Events
Company Information
Financial Information
Stock Data
Analyst Coverage
SEC Filings
Corporate Governance
Proxy Information
All SEC Filings
Investors
Overview
Investor Presentation
News / Events
Recent News / Events
Press Releases
Articles & Publications
IR Calendar
Email Alerts
Company Info
Overview
Profile
Management Team
Contacts
FAQ
Financial Info
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Overview
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Proxy Information
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Proxy Information
Filing Type:
View All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-A12B/A
8-K
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2020
2019
2018
2017
2015
Date
Form
Description
PDF
XBRL
Pages
12/21/20
8-K
Current report filing
Documents
EX-99.1
3
12/21/20
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-23.1
110
12/18/20
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
7
12/16/20
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
EX-99.1
8
12/02/20
8-K
Current report filing
Documents
EX-3.1
4
11/30/20
EFFECT
Notice of Effectiveness
1
11/27/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
11/24/20
8-K
Current report filing
3
11/24/20
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-5.1
EX-23.1
130
11/17/20
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32
38
1
2
3
4
5
6
7
8
9
10
Show
/
Refresh
/
Reset
/
Delete
Views until show:
5
Seconds until show:
5
By using this website, you consent to the use of cookies, as described in our
privacy policy
.
Accept